Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: a pilot study.

Abstract

“The lateral segment of the globus pallidus (GPl) is thought to be overactive in levodopa-induced dyskinesia in PD. Stimulation of cannabinoid receptors in the GPl reduces gamma-aminobutyric acid (GABA) reuptake and enhances GABA transmission and may thus alleviate dyskinesia. In a randomized, double-blind, placebo-controlled, crossover trial (n = 7), the authors demonstrate that the cannabinoid receptor agonist nabilone significantly reduces levodopa-induced dyskinesia in PD.”

http://www.ncbi.nlm.nih.gov/pubmed/11739835

2 thoughts on “Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: a pilot study.

Leave a Reply

Your email address will not be published. Required fields are marked *